Cite
HARVARD Citation
Di Raimondo, C. et al. (2022). Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis. Dermatologic therapy. 35 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Di Raimondo, C. et al. (2022). Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis. Dermatologic therapy. 35 (5), p. n/a. [Online].